Sentec in Italia
Sentec in Italia Monitoraggio transcutaneo continuo, accurato e [...]
Sentec in Italia Monitoraggio transcutaneo continuo, accurato e [...]
The Sentec Transcutaneous Monitoring System provides continuous visibility into patient ventilatory status, allowing clinicians to provide more proactive, timely interventions. By overcoming the limitations of end-tidal CO2 and providing better compatibility with all modes of ventilation, transcutaneous CO2 monitoring helps clinicians assess patient condition and the efficacy of treatment and ventilatory support strategies.
Lisa DeGuzman, RRT-NPS, RPSGT, CCSH discusses the role of transcutaneous CO2 monitoring in the Nemours Children’s Hospital Pediatric Sleep Center, highlighting its applications in detecting and guiding the management of sleep-disordered breathing among the pediatric population. In this adapted version of her webinar, you can explore the key takeaways and gain insights from the Nemours sleep lab.
How to Get Started with Transcutaneous Monitoring in the NICU [...]
How could transcutaneous monitoring enhance care in your pediatric ICU? In this whitepaper, PICU specialists from Children’s Memorial Hermann share case studies demonstrating how continuous visibility provided by transcutaneous CO2 monitoring supported their team’s patient care strategies.
How could IPV therapy make a difference for your patients? IPV therapy is a safe and well-tolerated airway clearance therapy that can be used with a diverse set of patient populations, care settings, and delivery interfaces.
In this article, Anne M. Geistkemper, MSc, RRT, RRT-NPS discusses the practical applications of transcutaneous CO2 monitoring in the NICU, its integration into neonatal care practices, and the evolution of this technology’s adoption in the Rush University Children’s Hospital NICU.
The IPV Therapy Clinical Evidence Brochure offers an overview of key clinical studies that highlight the efficacy and safety of intrapulmonary percussive ventilation (IPV) therapy across diverse patient populations. This brochure provides healthcare professionals with an understanding of the clinical utility and benefits of IPV therapy as demonstrated in the available evidence.
Blood draws for lab work are well-established as one of the main drivers of anemia of prematurity leading to a high rate of transfusion in the NICU. Learn more about the problem and how transcutaneous monitoring can be part of the solution.
Blood draws for lab work are well-established as one of the main drivers of anemia of prematurity leading to a high rate of transfusion in the NICU. Learn more about the problem and how transcutaneous monitoring can be part of the solution.